Clinical Trials Browser

Phase 2 × Ototoxicity × Methotrexate × Clear all

NCT01848457 2020-03-16

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Phase 2 Completed

13 enrolled 15 charts

Ototoxicity, Neoplasms, Osteosarcoma